William C. Ripka - Concepedia

Author

William C. Ripka

DuPont (United States)

Also Known As

W. C. RIPKA, W. C. Ripka, W.C. Ripka, WILLIAM C. RIPKA, William C Ripka, William C. Ripka, William Ripka

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

DuPont (United States)Wilmington University Michigan State University Experimental Station Novo Nordisk (Denmark)

About

William C. Ripka is an author at DuPont (United States) specializing in natural sciences, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	15	18	872
2	Biochemistry	15	17	856
3	Medicine	13	13	555
4	Engineering	6	6	162
5	Biomolecular Engineering	5	5	278

William C. Ripka

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B Lars Iversen, Henrik Sune Andersen, Sven Branner, Journal of Biological Chemistry Ptp1b Knockout MiceLow Molecular WeightBiochemistryRemarkable SelectivityNatural Sciences	2000	173
Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B Henrik Sune Andersen, Ole H. Olsen, Lars Iversen, Journal of Medicinal Chemistry Drug TargetSelective Ptp1b InhibitorsProtein-tyrosine Phosphatase 1BChemical BiologyMedicinal Chemistry	2002	131
Protein β-turn mimetics I. Design, synthesis, and evaluation in model cyclic peptides. William C. Ripka, George V. De Lucca, A. Bach, Tetrahedron Protein β-Turn MimeticsBiochemistryNatural SciencesPeptide EngineeringPeptide Library	1993	95
Computer modelling of the NAD binding site of ADP‐ribosylating toxins: active‐site structure and mechanism of NAD binding Mario Domenighini, Cesare Montecucco, William C. Ripka, Molecular Microbiology	1991	73
Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam Sulfonamide Moieties J. Edward Semple, David Rowley, Terence K. Brunck, Journal of Medicinal Chemistry P1-argininal DerivativesPharmaceutical ScienceThrombin InhibitorsAltmetric Attention ScorePharmacotherapy	1996	64
Development of Potent Non-Carbohydrate Imidazole-Based Small Molecule Selectin Inhibitors with Antiinflammatory Activity Deborah H. Slee, Suzanne J. Romano, Jinghua Yu, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical Chemistry	2001	63
High-throughput purification of compound libraries William C. Ripka, G.C. Barker, Jonathan Krakover Drug Discovery Today Targeted LibraryPurification MethodEngineeringBiotechnologyCompound Libraries	2001	53
Protein β-turn mimetics II: Design, synthesis, and evaluation in the cyclic peptide gramicidin S William C. Ripka, George V. De Lucca, A. Bach, Tetrahedron BiochemistryNatural SciencesPeptide EngineeringPeptide LibraryMolecular Biology	1993	47
A short and stereospecific synthesis of (±)-α-lycorane Chia‐Lin J. Wang, William C. Ripka, Pat N. Confalone Tetrahedron Letters EngineeringStereospecific SynthesisOrganic ChemistryStereoselective SynthesisNatural Product Synthesis	1984	47
Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors Jun-Young Choe, Scott W. Nelson, Kristen L. Arienti, Journal of Biological Chemistry	2003	39

Page 1